Press Releases

Press Releases

December 5, 2019
ESTA Reaches One Million Motiva Implants Milestone
NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on Women’s Health – initially in the breast aesthetics and reconstruction market – announced its one millionth Motiva® implant in market.
November 12, 2019
Establishment Labs Reports Third Quarter 2019 Financial Results
NEW YORK, Nov. 12, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the third quarter ended September 30, 2019.
November 7, 2019
Establishment Labs is Presenting at Two November Investor Conferences
Stephens Nashville Conference on November 13 Jefferies 2019 London Healthcare Conference on November 21 NEW YORK, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and
October 29, 2019
Establishment Labs to Announce Third Quarter 2019 Financial Results on November 12, 2019
NEW YORK, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the third quarter
October 22, 2019
Establishment Labs Recaps Fifth Annual World Symposium on Ergonomic Implants
Science, technology, safety and clinical outcomes of Motiva Implants® showcased as symposium breaks attendance records NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast
September 16, 2019
Establishment Labs Receives Notice of Allowance for Key U.S. Patent Application Covering Company’s Implant Surface Technology and Announces 510(k) Submission for its Tissue Expander
NEW YORK, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that the Company has received a Notice of Allowance from the U.S.
August 28, 2019
Establishment Labs to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference
NEW YORK , Aug. 28, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós will participate in a
August 13, 2019
Establishment Labs Reports Second Quarter 2019 Financial Results
NEW YORK , Aug. 13, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the second quarter ended June 30, 2019 .
July 30, 2019
Establishment Labs to Announce Second Quarter 2019 Financial Results on August 13, 2019
NEW YORK , July 30, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced the Company will release its financial results for the second quarter
June 17, 2019
Establishment Labs Announces Additional Financing and Improved Terms with Amendment to Existing Credit Agreement
NEW YORK, June 17, 2019 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has entered into an amendment to its existing credit agreement (the
Displaying 1 - 10 of 19